Insulin resistance as a cardiovascular risk factor in patients with ulcerative colitis

Close metadata

OBJECTIVE

To examine the contribution of insulin resistance (IR) to the development of cardiovascular diseases (CVD) in patients with ulcerative colitis (UC).

MATERIAL AND METHODS

A single-center observational cross-sectional case-control study. The main group included 17 patients with UC, arterial hypertension (AH), and coronary artery disease (CAD). The first comparison group (n=63) consisted of UC patients without CVD, the second comparison group (n=20) included patients with AH and stable CAD, and the control group (n=20) included healthy participants. The study involved surveys, physical examinations, BMI measurement, dynamometry, and blood tests for homocysteine, E-selectin, VCAM-1, ICAM-1, lipid profile, C-reactive protein (CRP), TNF-α, glucose, insulin, C-peptide, leptin, adiponectin, and soluble leptin receptors (SLR). The HOMA-IR index was calculated to assess IR.

RESULTS

Patients with CVD were older and had higher BMI. No association between HOMA-IR and the age of UC patients was found. Dynamopenia was identified in 32.5% of UC patients, and a connection between HOMA-IR and dynamopenia was established; CRP levels were significantly higher in UC patients with dynamopenia. TNF-α levels were higher in patients with both UC and CVD than in only UC patients. Higher HOMA-IR levels were observed in patients with CVD. A positive association was found between HOMA-IR and leptin, VLDL triglycerides, VCAM-1, and a negative association with SLR. A positive correlation was observed between adiponectin and HDL-C.

CONCLUSION

Increased IR in UC patients is facilitated by higher BMI and chronic inflammation, leading to the onset of AH at a younger age compared to comparison groups.

Keywords:

ulcerative colitis

insulin resistance

adipokines

cardiovascular diseases

dynamopenia

Authors:

Bikbavova G.R.

Omsk State Medical University

ORCID: 0000-0001-9252-9152

Livzan M.A.

Omsk State Medical University

ORCID: 0000-0002-6581-7017

Lisyutenko N.S.

Omsk State Medical University

ORCID: 0000-0003-4088-240X

Romanyuk A.E.

Omsk State Medical University

ORCID: 0000-0001-6308-4377

Zaporenko M.Yu.

Regional Clinical Hospital

Panova T.Yu.

Regional Clinical Hospital

ORCID: 0000-0002-0300-3528

Received:

30.05.2024

Accepted:

10.07.2024

List of references:

Shelygin YA, Ivashkin VT, Belousova EA, Reshetov IV, Maev IV, Achkasov SI, Abdulganieva DI, Alekseeva OA, Bakulin IG, Barysheva OY, Bolikhov KV, Vardanyan AV, Veselov AV, Veselov VV, Golovenko OV, Gubonina IV, Denisenko VL, Dolgushina AI, Kashnikov VN, Knyazev OV, Kostenko NV, Lakhin AV, Makarchuk PA, Moskalev AI, Nanaeva BA, Nikitin IG, Nikitina NV, Odintsova AK, Omelyanovskiy VV, Oshchepkov AV, Pavlenko VV, Poluektova EA, Sitkin SI, Sushkov OI, Tarasova LV, Tkachev AV, Timerbulatov VM, Uspenskaya YB, Frolov SA, Khlynova OV, Chashkova EY, Chesnokova OV, Shapina MV, Sheptulin AA, Shifrin OS, Shkurko TV, Shchukina OB. Ulcerative colitis (K51), adults. Koloproktologia. 2023;22(1):10-44. (In Russ.). https://doi.org/10.33878/2073-7556-2023-22-1-10-44
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. Gastroenterology and Hepatology. 2020;5(1):17-30. https://doi.org/10.1016/S2468-1253(19)30333-4
Bikbavova GR, Livzan MA, Sovalkin VI, Turchaninov DV, Lopatina OE, Tret’yakova TV, Akhramovich AP, Gordienko TS. Modern lifestyle and its impact on the ulcerative colitis incidence. Arkhiv vnutrennei meditsiny. 2019;9(3):188-194. (In Russ.). https://doi.org/10.20514/2226-6704-2019-9-3-188-193
Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel J-F, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031
Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot J-F, Peyrin-Biroulet L, Danese S. Comorbidities in inflammatory bowel disease: a call for action. Lancet. Gastroenterology and Hepatology. 2019;4(8):643-654. https://doi.org/10.1016/S2468-1253(19)30173-6
Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature Reviews. Gastroenterology and Hepatology. 2021;18(1):56-66. https://doi.org/10.1038/s41575-020-00360-x
He J, Zhang S, Qiu Y, Liu F, Liu Z, Tan J, Hu F, Wu X, Wang Y, Zhou L, Hu S, Chen M, Liao X, Zhuang X, Mao R. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United European Gastroenterology. 2023;11(1):19-30. https://doi.org/10.1002/ueg2.12351
Massironi S, Mulinacci G, Gallo C, Viganò C, Fichera M, Villatore A, Peretto G, Danese S. The oft-overlooked cardiovascular complications of inflammatory bowel disease. Expert Review of Clinical Immunology. 2023;19(4):375-391. https://doi.org/10.1080/1744666X.2023.2174971
D’Ascenzo F, Bruno F, Iannaccone M, Testa G, De Filippo O, Giannino G, Caviglia GP, Bernstein CN, De Ferrari GM, Bugianesi E, Armandi A, Ribaldone DG. Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. International Journal of Cardiology. 2023;378:96-104. https://doi.org/10.1016/j.ijcard.2023.02.042
Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, Bamias G, Barreiro-de Acosta M, Braithwaite T, Greuter T, Harwood C, Juillerat P, Lobaton T, Müller-Ladner U, Noor N, Pellino G, Savarino E, Schramm C, Soriano A, Stein JM, Uzzan M, van Rheenen PF, Vavricka SR, Vecchi M, Zuily S, Kucharzik T. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis. 2024;18(1):1-37. https://doi.org/10.1093/ecco-jcc/jjad108
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Rossiiskii kardiologicheskii zhurnal. 2022;27(7):5155. (In Russ.). https://doi.org/10.15829/1560-4071-2022-5155
Burisch J. Is hypertension an extra-intestinal manifestation of inflammatory bowel disease? United European Gastroenterology. 2023; 11(1):7-8. https://doi.org/10.1002/ueg2.12359
Rungoe C, Andersen NN, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends in Cardiovascular Medicine. 2015;25(8):699-704. https://doi.org/10.1016/j.tcm.2015.03.010
Jucan AE, Gavrilescu O, Dranga M, Popa IV, Mihai BM, Prelipcean CC, Mihai C. Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention. Life. 2022;12(8):1113. https://doi.org/10.3390/life12081113
Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. Journal of Cellular and Molecular Medicine. 2019;23(4):2343-2350. https://doi.org/10.1111/jcmm.14195
Bikbavova GR, Livzan MA, Lisyutenko NS, Martynenko OV, Indutny AV. Prevalence of overweight and obesity in patients with ulcerative colitis: a case-control study. Eksperimental’naya i klinicheskaya gastroenterologiya. 2023;(4):6-11. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-212-4-6-11
Uspenskiy YP, Ivanov SV, Mayorova OV, Fominykh JA. Inflammatory bowel disease and obesity: current state of issue. Meditsinskii alfavit. 2020;(37):29-34. (In Russ.). https://doi.org/10.33667/2078-5631-2020-37-29-34
Iazvennyi kolit. Klinicheskie rekomendatsii. 2022. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed January 30, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/193_1#doc_b
Arterial’naya gipertenziya u vzroslykh. Klinicheskie rekomendatsii. 2020. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed May 19, 2024. (In Russ.). https://scardio.ru/content/Guidelines/Clinic_rek_AG_2020.pdf
Stabil’naya ishemicheskaya bolezn’ serdtsa. Klinicheskie rekomendatsii. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. 2020. Accessed May 19, 2024. (In Russ.). https://scardio.ru/content/Guidelines/2020/Clinic_rekom_IBS-unlocked.pdf
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
Bicbavova GR, Drapkina OM, Livzan MA, Lisyutenko NS, Romanyuk AE. Cardiovascular risk factors in patients with ulcerative colitis. Terapevticheskii arkhiv. 2023;95(8):658-663. (In Russ.). https://doi.org/10.26442/00403660.2023.08.202338
Korneeva ON, Drapkina OM. Pathogenetic interaction of arterial hypertension and insulin resistance. Rossiiskii kardiologicheskii zhurnal. 2006;(5):100-103. (In Russ.).
Doğan AN, Kahraman R, Akar T. Evaluation of insulin resistance and beta cell activity in patients with inflammatory bowel disease. European Review for Medical and Pharmacological Sciences. 2022;26(11):39-89-3994. https://doi.org/10.26355/eurrev_202206_28969
Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, Grunberger G, Handelsman Y, Hennekens CH, Hurley DL, McGill J, Palumbo P, Umpierrez G. On behalf of the AACE obesity scientific C. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocrine Practice. 2014;20(9):977-989. https://doi.org/10.4158/EP14280.PS

Close metadata